Redeye

Corline Biomedical (Q3 Review): A soft quarter, as signalled by the guidance

Källa: MFN
Oanalyserad

Redeye’s analyst published a Research Update on Corline Biomedical.Click here to read the articleMake sure to add Corline Biomedical to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies

About Redeye Nordic Growth AB

This is a press release from Redeye Nordic Growth AB, a equity research firm specializing in Nordic growth companies within Tech and Life Science. Redeye Nordic Growth is a part of the Redeye group, which also offers services within corporate finance advisory and fund management. https://services.redeye.se/

Attachments

Corline Biomedical (Q3 Review): A soft quarter, as signalled by the guidance

Redeye: Corline Biomedical (Q3 Review): A soft quarter, as signalled by the guidance - pressmeddelande och analys | Tickr